
|Articles|March 15, 2002
New mindset suggested for prescribing beta-blockers
Since the release of the topical beta-blocker timolol maleate (Timoptic, Merck) some 2 decades ago, glaucoma patients have been the beneficiaries of a cascade of new IOP-lowering pharmaceuticals.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
3
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
4
Eye exams could enable earlier detection of systemic disease
5



























